Authors

• Cristina Saavedra (ORCID: https://orcid.org/0000-0002-1063-2306)
• Patricia Cortez
• Heidrun Forstner
• Cristina Saura-Manich
• Isabel Blancas (ORCID: https://orcid.org/0000-0002-5867-6615)
• Felipe Slebe (ORCID: https://orcid.org/0000-0002-9406-6208)
• Carlos Jiménez‐Cortegana (ORCID: https://orcid.org/0000-0001-6956-7740)
• Rupert Bartsch (ORCID: https://orcid.org/0000-0002-4384-6917)
• Manuel Ruíz‐Borrego (ORCID: https://orcid.org/0000-0002-1181-5622)
• Jose Antonio Guerrero-Martinez (ORCID: https://orcid.org/0000-0003-0044-8756)
• Marta Vaz Batista (ORCID: https://orcid.org/0000-0001-5791-2092)
• Matthias Preusser (ORCID: https://orcid.org/0000-0003-3541-2315)
• Juliana C. Santos (ORCID: https://orcid.org/0000-0003-4148-9570)
• Maximilian Marhold (ORCID: https://orcid.org/0000-0001-8439-3312)
• Cristina Morales (ORCID: https://orcid.org/0000-0002-7126-6565)
• Marta Campolier (ORCID: https://orcid.org/0000-0002-7168-2534)
• Beate Rottenmanner

Institutions

• Hebron University (PS)
• Universidad de Granada (ES)
• Hospital Prof. Dr. Fernando Fonseca (PT)
• MedSIR (Spain) (ES)
• Instituto de Investigación Biosanitaria de Granada (ES)
• Clínica Santa María (CO)
• Hospital Universitario Reina Sofía (ES)
• Vall d'Hebron Hospital Universitari (ES)
• Hospital Universitario Virgen del Rocío (ES)
• Hospital Universitario Ramón y Cajal (ES)
• Vall d'Hebron Institute of Oncology (ES)
• Medical University of Vienna (AT)

Publication Details

Journal

Future Oncology

Published

2025-02-28

DOI

https://doi.org/10.1080/14796694.2025.2470604

Citations

4

Primary Topic

HER2/EGFR in Cancer Research

Type

article

Field-Weighted Citation Impact

4.18

Funders

• Daiichi Sankyo Europe